These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 1314948
1. Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics. Nair N, Davis RJ, Robinson HL. Mol Cell Biol; 1992 May; 12(5):2010-6. PubMed ID: 1314948 [Abstract] [Full Text] [Related]
3. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. Huang Y, Kim SO, Jiang J, Frank SJ. J Biol Chem; 2003 May 23; 278(21):18902-13. PubMed ID: 12642595 [Abstract] [Full Text] [Related]
4. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites. Fan YX, Wong L, Deb TB, Johnson GR. J Biol Chem; 2004 Sep 10; 279(37):38143-50. PubMed ID: 15231819 [Abstract] [Full Text] [Related]
9. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential. Shu HK, Pelley RJ, Kung HJ. Proc Natl Acad Sci U S A; 1990 Dec 08; 87(23):9103-7. PubMed ID: 1979168 [Abstract] [Full Text] [Related]
10. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Di Fiore PP, Segatto O, Lonardo F, Fazioli F, Pierce JH, Aaronson SA. Mol Cell Biol; 1990 Jun 08; 10(6):2749-56. PubMed ID: 2188097 [Abstract] [Full Text] [Related]
11. Nonphosphorylatable substrate analogs selectively block autophosphorylation and activation of the insulin receptor, epidermal growth factor receptor, and pp60v-src kinases. Shoelson SE, White MF, Kahn CR. J Biol Chem; 1989 May 15; 264(14):7831-6. PubMed ID: 2498306 [Abstract] [Full Text] [Related]
12. The erbB-2 mitogenic signaling pathway: tyrosine phosphorylation of phospholipase C-gamma and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. Fazioli F, Kim UH, Rhee SG, Molloy CJ, Segatto O, Di Fiore PP. Mol Cell Biol; 1991 Apr 15; 11(4):2040-8. PubMed ID: 1672440 [Abstract] [Full Text] [Related]
14. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product. Mikami Y, Davis JG, Dobashi K, Dougall WC, Myers JN, Brown VI, Greene MI. Proc Natl Acad Sci U S A; 1992 Aug 15; 89(16):7335-9. PubMed ID: 1354355 [Abstract] [Full Text] [Related]
17. Autophosphorylation of the intracellular domain of the epidermal growth factor receptor results in different effects on its tyrosine kinase activity with various peptide substrates. Phosphorylation of peptides representing Tyr(P) sites of phospholipase C-gamma. Hsu CY, Hurwitz DR, Mervic M, Zilberstein A. J Biol Chem; 1991 Jan 05; 266(1):603-8. PubMed ID: 1845982 [Abstract] [Full Text] [Related]
18. Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. Galisteo ML, Dikic I, Batzer AG, Langdon WY, Schlessinger J. J Biol Chem; 1995 Sep 01; 270(35):20242-5. PubMed ID: 7657591 [Abstract] [Full Text] [Related]
20. Kinetic parameters of the protein tyrosine kinase activity of EGF-receptor mutants with individually altered autophosphorylation sites. Honegger A, Dull TJ, Szapary D, Komoriya A, Kris R, Ullrich A, Schlessinger J. EMBO J; 1988 Oct 01; 7(10):3053-60. PubMed ID: 3181128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]